Sensei Biotherapeutics, Inc. – NASDAQ:SNSE

Sensei Biotherapeutics stock price today

$7.9
+7.40
+1486.35%
Financial Health
0
1
2
3
4
5
6
7
8
9

Sensei Biotherapeutics stock price monthly change

-31.30%
month

Sensei Biotherapeutics stock price quarterly change

-31.30%
quarter

Sensei Biotherapeutics stock price yearly change

-28.43%
year

Sensei Biotherapeutics key metrics

Market Cap
11.50M
Enterprise value
35.06M
P/E
-0.93
EV/Sales
N/A
EV/EBITDA
-0.50
Price/Sales
N/A
Price/Book
0.43
PEG ratio
0.02
EPS
-1.21
Revenue
N/A
EBITDA
-33.16M
Income
-31.91M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Sensei Biotherapeutics stock price history

Sensei Biotherapeutics stock forecast

Sensei Biotherapeutics financial statements

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE): Profit margin
Jun 2023 0 -9.38M
Sep 2023 0 -7.12M
Dec 2023 2.84M -7.41M -260.51%
Mar 2024 0 -7.99M
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE): Analyst Estimates
2025 0 -41.28M
2026 0 -48.29M
2027 0 -38.57M
2028 0 -38.57M
  • Analysts Price target

  • Financials & Ratios estimates

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE): Debt to assets
Jun 2023 89580000 10.37M 11.59%
Sep 2023 81658000 10.65M 13.05%
Dec 2023 74374000 9.47M 12.75%
Mar 2024 66694999 8.22M 12.33%
Sensei Biotherapeutics, Inc. (NASDAQ:SNSE): Cash Flow
Jun 2023 -9.46M 19.52M -7.94M
Sep 2023 -4.66M 8.31M -2.53M
Dec 2023 -6.16M 8.26M -431K
Mar 2024 -7.61M 5.77M -209K

Sensei Biotherapeutics alternative data

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE): Employee count
Aug 2023 27
Sep 2023 23
Oct 2023 23
Nov 2023 23
Dec 2023 26
Jan 2024 26
Feb 2024 26
Mar 2024 28
Apr 2024 28
May 2024 28
Jun 2024 28
Jul 2024 27

Sensei Biotherapeutics other data

1.08% -7.52%
of SNSE is owned by hedge funds
330.31K -2.31M
shares is hold by hedge funds

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE): Insider trades (number of shares)
Period Buy Sel
Feb 2023 2200 0
Jun 2023 0 955738
Sep 2023 500 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
CELEBI JOHN director, officer.. Common Stock 500 $0.85 $425
Sale
APEIRON INVESTMENT GROUP LTD. 10 percent owner
Common Stock 955,738 $1.58 $1,510,066
Purchase
APEIRON INVESTMENT GROUP LTD. 10 percent owner
Common Stock 1,100 $1.6 $1,762
Purchase
APEIRON INVESTMENT GROUP LTD. 10 percent owner
Common Stock 1,100 $1.62 $1,777
Purchase
CAMBRIAN BIOPHARMA INC 10 percent owner
Common Stock 1,203 $3.2 $3,850
Purchase
PEYER JAMES director, 10 percent owner
Common Stock 1,203 $3.2 $3,850
Purchase
CAMBRIAN BIOPHARMA INC 10 percent owner
Common Stock 2,458 $3.6 $8,849
Purchase
PEYER JAMES director, 10 percent owner
Common Stock 2,458 $3.6 $8,849
Purchase
CAMBRIAN BIOPHARMA INC 10 percent owner
Common Stock 42 $3.6 $151
Purchase
PEYER JAMES director, 10 percent owner
Common Stock 42 $3.6 $151
Patent
Application
Filling date: 1 May 2020 Issue date: 5 Nov 2020
Application
Filling date: 18 Oct 2019 Issue date: 23 Apr 2020
Application
Filling date: 10 May 2019 Issue date: 14 Nov 2019
Wednesday, 27 November 2024
globenewswire.com
Thursday, 14 November 2024
globenewswire.com
Tuesday, 29 October 2024
globenewswire.com
Wednesday, 4 September 2024
globenewswire.com
globenewswire.com
Tuesday, 6 August 2024
globenewswire.com
Thursday, 30 May 2024
globenewswire.com
Friday, 24 May 2024
investorplace.com
Thursday, 23 May 2024
globenewswire.com
Friday, 10 May 2024
businesswire.com
Thursday, 9 May 2024
globenewswire.com
Wednesday, 24 April 2024
globenewswire.com
Tuesday, 9 April 2024
GlobeNewsWire
Wednesday, 6 March 2024
GlobeNewsWire
Wednesday, 7 February 2024
GlobeNewsWire
Wednesday, 25 October 2023
GlobeNewsWire
Wednesday, 13 September 2023
GlobeNewsWire
Wednesday, 30 August 2023
GlobeNewsWire
Thursday, 13 April 2023
GlobeNewsWire
Tuesday, 14 March 2023
GlobeNewsWire
Tuesday, 14 February 2023
GlobeNewsWire
Wednesday, 2 November 2022
GlobeNewsWire
Wednesday, 5 October 2022
GlobeNewsWire
Wednesday, 21 September 2022
GlobeNewsWire
Tuesday, 23 August 2022
GlobeNewsWire
Monday, 21 February 2022
PennyStocks
Friday, 1 October 2021
GlobeNewsWire
  • What's the price of Sensei Biotherapeutics stock today?

    One share of Sensei Biotherapeutics stock can currently be purchased for approximately $7.9.

  • When is Sensei Biotherapeutics's next earnings date?

    Unfortunately, Sensei Biotherapeutics's (SNSE) next earnings date is currently unknown.

  • Does Sensei Biotherapeutics pay dividends?

    No, Sensei Biotherapeutics does not pay dividends.

  • How much money does Sensei Biotherapeutics make?

    Sensei Biotherapeutics has a market capitalization of 11.50M.

  • What is Sensei Biotherapeutics's stock symbol?

    Sensei Biotherapeutics, Inc. is traded on the NASDAQ under the ticker symbol "SNSE".

  • What is Sensei Biotherapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Sensei Biotherapeutics?

    Shares of Sensei Biotherapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Sensei Biotherapeutics's key executives?

    Sensei Biotherapeutics's management team includes the following people:

    • Mr. John K. Celebi Pres, Chief Executive Officer & Director(age: 53, pay: $532,630)
    • Dr. Robert Hamilton Pierce M.D. Chief Scientific Officer(age: 61, pay: $488,030)
  • How many employees does Sensei Biotherapeutics have?

    As Jul 2024, Sensei Biotherapeutics employs 27 workers, which is 4% less then previous month and 4% less then previous quarter.

  • When Sensei Biotherapeutics went public?

    Sensei Biotherapeutics, Inc. is publicly traded company for more then 4 years since IPO on 4 Feb 2021.

  • What is Sensei Biotherapeutics's official website?

    The official website for Sensei Biotherapeutics is senseibio.com.

  • Where are Sensei Biotherapeutics's headquarters?

    Sensei Biotherapeutics is headquartered at 451 D Street, Rockville, MD.

  • How can i contact Sensei Biotherapeutics?

    Sensei Biotherapeutics's mailing address is 451 D Street, Rockville, MD and company can be reached via phone at +240 2438000.

Sensei Biotherapeutics company profile:

Sensei Biotherapeutics, Inc.

senseibio.com
Exchange:

NASDAQ

Full time employees:

28

Industry:

Biotechnology

Sector:

Healthcare

Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor potential of T-cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company also develops SNS-101, a monoclonal antibody for the treatment of cancer; and SNS-401-NG, an ImmunoPhage vaccine targeting multiple tumor antigens. It has a collaboration with The University of Washington to research and develop Merkel cell carcinoma vaccine. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.

451 D Street
Rockville, MD 02210

CIK: 0001829802
ISIN: US81728A1088
CUSIP: 81728A108